The results of the first randomized, placebo-controlled trial of dimethyl fumarate in a cohort of participants with radiologically isolated syndrome showed efficacy against the risk of a first clinical demyelinating event. The findings pave the way for preventive medicine in multiple sclerosis and highlight the need for more precise prognostication of risk.
A first step towards preventive medicine in multiple sclerosis / Amato, Maria Pia; Portaccio, Emilio. - In: NATURE REVIEWS. NEUROLOGY. - ISSN 1759-4766. - ELETTRONICO. - 19:(2023), pp. 134-135. [10.1038/s41582-022-00769-9]
A first step towards preventive medicine in multiple sclerosis
Amato, Maria Pia
;Portaccio, Emilio
2023
Abstract
The results of the first randomized, placebo-controlled trial of dimethyl fumarate in a cohort of participants with radiologically isolated syndrome showed efficacy against the risk of a first clinical demyelinating event. The findings pave the way for preventive medicine in multiple sclerosis and highlight the need for more precise prognostication of risk.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
